Q1 Earnings Estimate for ITRM Issued By HC Wainwright
Iterum Therapeutics plc (NASDAQ:ITRM – Free Report) – Equities research analysts at HC Wainwright issued their Q1 2025 EPS estimates for Iterum Therapeutics in a report released on Thursday, May 8th. HC Wainwright analyst M. Keller anticipates that the company will earn ($0.15) per share for the quarter. HC Wainwright has a “Buy” rating and […]
Iterum Therapeutics plc (NASDAQ:ITRM – Free Report) – Equities research analysts at HC Wainwright issued their Q1 2025 EPS estimates for Iterum Therapeutics in a report released on Thursday, May 8th. HC Wainwright analyst M. Keller anticipates that the company will earn ($0.15) per share for the quarter. HC Wainwright has a “Buy” rating and […]
